(Total Views: 569)
Posted On: 06/24/2020 9:24:30 AM
Post# of 155052
Re: Riztheinvestor #38872
The ph2 trial is 22 weeks long. A oh 3 would need to be designed yet. May be longer in duration and would have a larger patient population.
I think most likely a ph 3 would be required, but there are growing thoughts that the more indications we get approved, and the more safety data we compile, the more likely we get approvals after ph 2
I think most likely a ph 3 would be required, but there are growing thoughts that the more indications we get approved, and the more safety data we compile, the more likely we get approvals after ph 2
(0)
(0)
